CytomX Therapeutics, Inc. ($CTMX)
Ogden Christopher โ Chief Financial Officer
Shares
90,000
Price
$0.00
Total Value
$0.00
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Ogden Christopher |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Feb 2, 2026 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 4, 2026 |
| Document Date | Feb 2, 2026 |
| Shares Purchased | 90,000 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 316,271 |
| Derivative | No |
| Accession Number | 0001610717-26-000040 |
| Document | View SEC Filing |